Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Myomo Inc MYO

Healthcare Medical Devices
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial... see more

Recent & Breaking News (NYSEAM:MYO)

Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Business Wire January 17, 2024

Myomo Reports Preliminary Fourth Quarter Revenue and Backlog

Business Wire January 17, 2024

Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations

Business Wire November 7, 2023

CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting

Business Wire November 6, 2023

Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category

Business Wire November 2, 2023

Myomo to Report Third Quarter Financial Results on November 7, 2023

Business Wire October 31, 2023

Myomo Announces Closing of $4.4 Million Public Offering

Business Wire August 29, 2023

Myomo Announces Pricing of $4.4 Million Public Offering

Business Wire August 25, 2023

Myomo, Inc. Announces Proposed Public Offering

Business Wire August 24, 2023

 Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims

Business Wire August 24, 2023

Myomo Announces Two German Social Court Rulings Ordering MyoPro® Reimbursement

Business Wire August 21, 2023

Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics

Business Wire August 9, 2023

Myomo to Report Second Quarter Financial Results on August 9, 2023

Business Wire August 2, 2023

Myomo To Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest

Business Wire June 14, 2023

Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue

Business Wire May 10, 2023

Myomo to Report First Quarter Financial Results on May 10, 2023

Business Wire May 3, 2023

Myomo Receives Technology License Fee Payment from China Joint Venture Company

Business Wire April 10, 2023

Myomo Makes NYSE American Section 610(b) Public Announcement

Business Wire March 15, 2023

Myomo Reports Fourth Quarter and Full Year 2022 Financial Results

Business Wire March 13, 2023

Myomo to Report Third Quarter Financial Results on March 13, 2023

Business Wire March 6, 2023